Alpha-Synuclein Structure and Parkinson's Disease – Lessons and Emerging Principles

Richard Meade, David P. Fairlie, Jody Mason

Research output: Contribution to journalArticle

Abstract

Alpha-synuclein (αS) is the major constituent of Lewy bodies and a pathogenic hallmark of all synucleinopathathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). All diseases are determined by αS aggregate deposition but can be separated into distinct pathological phenotypes and diagnostic criteria. Here we attempt to reinterpret the literature, particularly in terms of how αS structure may relate to pathology. We do so in the context of a rapidly evolving field, taking into account newly revealed structural information on both native and pathogenic forms of the αS protein, including recent solid state NMR and cryoEM fibril structures. We discuss how these new findings impact on current understanding of αS and PD, and where this information may direct the field.

Original languageEnglish
Article number29
Pages (from-to)1-14
Number of pages14
JournalMolecular Neurodegeneration
Volume14
Issue number1
DOIs
Publication statusPublished - 22 Jul 2019

Keywords

  • Alpha-synuclein
  • Amyloid
  • CryoEM
  • Oligomers
  • Parkinson's disease
  • Protein-protein interactions

ASJC Scopus subject areas

  • Molecular Biology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Alpha-Synuclein Structure and Parkinson's Disease – Lessons and Emerging Principles. / Meade, Richard; Fairlie, David P.; Mason, Jody.

In: Molecular Neurodegeneration, Vol. 14, No. 1, 29, 22.07.2019, p. 1-14.

Research output: Contribution to journalArticle

@article{c673fe7d8ceb4e85ad65b61da12405cb,
title = "Alpha-Synuclein Structure and Parkinson's Disease – Lessons and Emerging Principles",
abstract = "Alpha-synuclein (αS) is the major constituent of Lewy bodies and a pathogenic hallmark of all synucleinopathathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). All diseases are determined by αS aggregate deposition but can be separated into distinct pathological phenotypes and diagnostic criteria. Here we attempt to reinterpret the literature, particularly in terms of how αS structure may relate to pathology. We do so in the context of a rapidly evolving field, taking into account newly revealed structural information on both native and pathogenic forms of the αS protein, including recent solid state NMR and cryoEM fibril structures. We discuss how these new findings impact on current understanding of αS and PD, and where this information may direct the field.",
keywords = "Alpha-synuclein, Amyloid, CryoEM, Oligomers, Parkinson's disease, Protein-protein interactions",
author = "Richard Meade and Fairlie, {David P.} and Jody Mason",
year = "2019",
month = "7",
day = "22",
doi = "10.1186/s13024-019-0329-1",
language = "English",
volume = "14",
pages = "1--14",
journal = "Molecular Neurodegeneration",
issn = "1750-1326",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Alpha-Synuclein Structure and Parkinson's Disease – Lessons and Emerging Principles

AU - Meade, Richard

AU - Fairlie, David P.

AU - Mason, Jody

PY - 2019/7/22

Y1 - 2019/7/22

N2 - Alpha-synuclein (αS) is the major constituent of Lewy bodies and a pathogenic hallmark of all synucleinopathathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). All diseases are determined by αS aggregate deposition but can be separated into distinct pathological phenotypes and diagnostic criteria. Here we attempt to reinterpret the literature, particularly in terms of how αS structure may relate to pathology. We do so in the context of a rapidly evolving field, taking into account newly revealed structural information on both native and pathogenic forms of the αS protein, including recent solid state NMR and cryoEM fibril structures. We discuss how these new findings impact on current understanding of αS and PD, and where this information may direct the field.

AB - Alpha-synuclein (αS) is the major constituent of Lewy bodies and a pathogenic hallmark of all synucleinopathathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). All diseases are determined by αS aggregate deposition but can be separated into distinct pathological phenotypes and diagnostic criteria. Here we attempt to reinterpret the literature, particularly in terms of how αS structure may relate to pathology. We do so in the context of a rapidly evolving field, taking into account newly revealed structural information on both native and pathogenic forms of the αS protein, including recent solid state NMR and cryoEM fibril structures. We discuss how these new findings impact on current understanding of αS and PD, and where this information may direct the field.

KW - Alpha-synuclein

KW - Amyloid

KW - CryoEM

KW - Oligomers

KW - Parkinson's disease

KW - Protein-protein interactions

UR - http://www.scopus.com/inward/record.url?scp=85069778229&partnerID=8YFLogxK

U2 - 10.1186/s13024-019-0329-1

DO - 10.1186/s13024-019-0329-1

M3 - Article

VL - 14

SP - 1

EP - 14

JO - Molecular Neurodegeneration

JF - Molecular Neurodegeneration

SN - 1750-1326

IS - 1

M1 - 29

ER -